Thomas White International’s Emergent Biosolutions EBS Stock Holding History

Thomas White International’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-200	Closed	-$7K	–	335
2016 Q4	$7K	Hold	200	–	–	﹤0.01%	257
2016 Q3	$6K	Hold	200	–	–	﹤0.01%	236
2016 Q2	$6K	Sell	200 -410	-67%	-$16.1K	﹤0.01%	223
2016 Q1	$22K	Hold	610	–	–	﹤0.01%	213
2015 Q4	$24K	Hold	610	–	–	﹤0.01%	222
2015 Q3	$17K	Hold	610	–	–	﹤0.01%	280
2015 Q2	$20K	Buy	610 +195	+47%	+$6.04K	﹤0.01%	272
2015 Q1	$12K	Hold	415	–	–	﹤0.01%	294
2014 Q4	$11K	Hold	415	–	–	﹤0.01%	296
2014 Q3	$9K	Hold	415	–	–	﹤0.01%	309
2014 Q2	$9K	Hold	415	–	–	﹤0.01%	320
2014 Q1	$10K	Hold	415	–	–	﹤0.01%	299
2013 Q4	$10K	Hold	415	–	–	﹤0.01%	314
2013 Q3	$8K	Hold	415	–	–	﹤0.01%	336
2013 Q2	$6K	Buy	+415	New	+$6.01K	﹤0.01%	323

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Thomas White International's EBS Position: Q1 2017 in Review

Thomas White International sold out of Emergent Biosolutions (EBS) in Q1 2017, closing a stake of 200 shares — an estimated $7K sold.

Thomas White International first reported a position in EBS in Q2 2013 and held it in 15 quarters. The position peaked at $24K in Q4 2015. 176 funds tracked by Wall St. Rank hold EBS as of Q1 2017.

Thomas White International reported no remaining Emergent Biosolutions position as of Q1 2017 after selling out during the quarter.
Thomas White International sold 200 Emergent Biosolutions shares in Q1 2017, an estimated $7K.
Thomas White International first reported a position in Emergent Biosolutions in Q2 2013 and held it in 15 quarters.
Thomas White International's Emergent Biosolutions position peaked at $24K in Q4 2015.
176 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2017.

Based on Thomas White International's 13F filing for Q1 2017, filed 10 May 2017.